WallStreetZenWallStreetZen

NASDAQ: VTVT
Vtv Therapeutics Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

VTVT past revenue growth

How has VTVT's revenue growth performed historically?
Company
-100%
Industry
145.22%
Market
17.76%
VTVT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
VTVT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
VTVT's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

VTVT earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$20.3M
Current Profit Margin
0%

VTVT Return on Equity

Insufficient data to display

Be the first to know when VTVT announces earnings.

VTVT Return on Assets

Current Company
-104.9%
Current Industry
2.9%
VTVT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

VTVT Return on Capital Employed

Current Company
-5,071.93%
Current Industry
19.5%
VTVT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VTVT vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
VTVT$0.00-$20.15M-$20.25M-100.00%N/A
GNLX$170.00k-$27.63M-$28.30M-98.46%N/A
ATRA$8.57M-$254.20M-$276.13M-35.08%N/A
AFMD$8.99M-$114.03M-$115.15M-19.55%N/A
ALRN$0.00-$15.61M-$15.73MN/AN/A
View Top Biotech Stocks

VTVT earnings dates

Next earnings date
Jun 11, 2024

Vtv Therapeutics Earnings & Revenue FAQ

What were VTVT's earnings last quarter?

On Invalid Date, Vtv Therapeutics (NASDAQ: VTVT) reported Q4 2023 earnings per share (EPS) of -$1.31, up 33.84% year over year. Total Vtv Therapeutics earnings for the quarter were -$3.48 million. In the same quarter last year, Vtv Therapeutics's earnings per share (EPS) was -$1.98.

If you're new to stock investing, here's how to buy Vtv Therapeutics stock.

What was VTVT's earnings growth in the past year?

As of Q2 2024, Vtv Therapeutics's earnings has grown year over year. Vtv Therapeutics's earnings in the past year totalled -$20.25 million.

What is VTVT's earnings date?

Vtv Therapeutics's earnings date is Invalid Date. Add VTVT to your watchlist to be reminded of VTVT's next earnings announcement.

What was VTVT's revenue last quarter?

On Invalid Date, Vtv Therapeutics (NASDAQ: VTVT) reported Q4 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Vtv Therapeutics's revenue was $9.00 thousand.

What was VTVT's revenue growth in the past year?

As of Q2 2024, Vtv Therapeutics's revenue has grown -100% year over year. This is 245.22 percentage points lower than the US Biotechnology industry revenue growth rate of 145.22%. Vtv Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.